Skip to main content
PMC home page
PLOS ONE logoLink to PLOS ONE
. 2013 Sep 5;8(9):e72313. doi: 10.1371/journal.pone.0072313

Comparison of Stress-Induced Changes in Adults and Pups: Is Aldosterone the Main Adrenocortical Stress Hormone during the Perinatal Period in Rats?

János Varga 1, Szilamér Ferenczi 2, Krisztina J Kovács 2, Alexandra Garafova 3, Daniela Jezova 3, Dóra Zelena 1,*
Editor: Andrew Wolfe4
PMCID: PMC3763995  PMID: 24039750

Abstract

Positive developmental impact of low stress-induced glucocorticoid levels in early development has been recognized for a long time, while possible involvement of mineralocorticoids in the stress response during the perinatal period has been neglected. The present study aimed at verifying the hypothesis that balance between stress-induced glucocorticoid and mineralocorticoid levels is changing during postnatal development. Hormone responses to two different stressors (insulin-induced hypoglycaemia and immune challenge induced by bacterial lipopolysaccharid) measured in 10-day-old rats were compared to those in adults. In pups corticosterone responses to both stressors were significantly lower than in adults, which corresponded well with the stress hyporesponsive period. Importantly, stress-induced elevations in aldosterone concentration were significantly higher in pups compared both to corticosterone elevations and to those in adulthood with comparable adrenocorticotropin concentrations in the two age groups. Greater importance of mineralocorticoids compared to glucocorticoids in postnatal period is further supported by changes in gene expression and protein levels of gluco- (GR) and mineralocorticoid receptors (MR) and selected enzymes measured by quantitative PCR and immunohystochemistry in the hypothalamus, hippocampus, prefrontal cortex, liver and kidney. Gene expression of 11beta-hydroxysteroid dehydrogenase 2 (11β-HSD2), an enzyme enabling preferential effects of aldosterone on mineralocorticoid receptors, was higher in 10-day-old pups compared to adult animals. On the contrary, the expression and protein levels of GR, MR and 11β-HSD1 were decreased. Presented results clearly show higher stress-induced release of aldosterone in pups compared to adults and strongly suggest greater importance of mineralocorticoids compared to glucocorticoids in stress during the postnatal period.

Introduction

Aldosterone is the main mineralocorticoid hormone involved in the control of water-electrolyte balance [1]. Together with glucocorticoids, aldosterone is released from the adrenal cortex in response to several stress stimuli [2]. Stimulation of aldosterone release by acute and chronic stressors is mediated by angiotensin II and adrenocorticotropic hormone (ACTH) [3], [4].

In stress research, less attention has been given to aldosterone compared to cortisol and corticosterone (the main glucocorticoids in humans and rodents, respectively) mainly because they are acting on the same receptors and glucocorticoids are the dominant players. They have two types of receptors, namely the low affinity glucocorticoid receptor (GR) and the high affinity mineralocorticoid receptor (MR) [5]. Thus, GRs are activated when glucocorticoid concentrations are high as occurs during stress or at the peak of the circadian rhythm, while MRs are thought to be close to saturation at baseline, non-stress conditions and exhibit tonic influence on hypothalamo-pituitary-adrenocortical axis (HPA) output [6], [7].

Since concentration of circulating glucocorticoids is 2–3 order higher than that of aldosterone, in aldosterone target tissues such as in the kidney, only the presence of 11-beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2) allows steroid binding to receptors via conversion the competing corticosterone and cortisol into inactive metabolites [8]. On the other hand, 11β-HSD1 catalyses an opposite reaction by increasing active glucocorticoids in their target tissues (e.g. liver, brain).

Effects of stress-induced aldosterone release on the salt-water homeostasis have impact on the control of blood pressure and cardiovascular functions as well [9]. Recent findings revealed that the physiological and pathophysiological role of aldosterone may be much broader. Although brain MRs are related to behavioral expressions of mood, the action of the mineralocorticoid hormones in this respect was neglected due to very low levels of the enzyme 11β-HSD2 [7]. However, evidence is accumulating that certain brain regions contain MRs that bind preferentially mineralocorticoids [10]. Indeed, anxiogenic and depressogenic effects of aldosterone have been recently described [11]–[13].

Another important issue could be the involvement of aldosterone in neuroendocrine responses to stress stimuli during the postnatal period. Even though there are reports indicating that postnatal stress may have implications on the salt intake in the adulthood [14], this topic has been mostly neglected. During the first two weeks of life (from about days 4 to 14) rat pups show reduced capacity to secrete corticosterone in response to several stimuli [15]–[17]. This period has been termed the stress hyporesponsive period (SHRP). Because of the serious long-term consequences of high glucocorticoid levels during the perinatal period (e.g. hypertension, hyperlipidaemia, diabetes [18], [19]) it is crucial to maintain their levels at minimum. Though the low total corticosterone concentrations in pups are partially offset by low plasma corticosteroid-binding globulin (CBG) levels and its reduction during stress [20], [21], the time and stressor specific glucocorticoid hyporesponsiveness is still present not only in rodents [15], [22], but also in humans [23] and other vertebrates [24]. At the same time, hormone responses and coping with aversive stress stimuli are indispensable to life.

In the present studies, we aimed to test the hypothesis that the balance between stress-induced glucocorticoid and mineralocorticoid levels is changing during development. More specifically, we hypothesized that during SHRP, which is associated with decreased glucocorticoid secretion, mineralocorticoids are the dominant adrenocortical steroids released during stress.

Materials and Methods

Animals

Adult (265–415 g, 10–12-week-old) and postnatal (28–31 g, 10-day-old) male Wistar rats were investigated (Charles River, Hungary). Rats were kept in controlled environment (23±1°C, 50–70% humidity, 12 h light starting at 07∶00 h) and given commercial rat chow (Charles River, Budapest, Hungary) and tap water ad libitum.

Ethics Statement

The experiments were performed in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC), and were reviewed and approved by the Animal Welfare Committee of the Institute of Experimental Medicine (MÁB 22.1/2654/003/2007).

Stress models

Insulin-induced hypoglycaemia

Stress of hypoglycaemia was induced in fasted rats by intraperitoneal (i.p.) insulin injection (Actrapid, Novo Nordisk, Bagsvaerd, Denmark) at the dose of 3IU/1 ml/kg of body weight in saline. Adult rats were fasted for 18 h, while 10-day-old pups for only 4 h (the entire litter was removed from the dam and put into a new cage with bedding and external heating) to achieve comparable degree of starvation. Rats of control groups were injected with the same volume of vehicle (0.9% NaCl). Separate groups of rats were decapitated at 60 and 90 min after i.p. injection. As the HPA axis of pups reacts to different stimuli with a delay, we took the 90 min results as more representative and presented these results in the graphic form. Data obtained at 60 min are in a table. Blood glucose levels were measured by commercially available analyser (D-Cont Personal, 77 Elektronika Kft., Budapest, Hungary) at the time of decapitation.

Immune challenge induced by lipopolysaccharide (LPS) injection

Administration of LPS represents a strong stressor simulating bacterial infection. Escherichia coli LPS, serotype 0111: B4 (Sigma, Budapest, Hungary) was used at the dose of 100 μg/1 ml/kg of body weight i.p. Rats of control groups were injected with the same volume of vehicle (0.9% NaCl). Animals were killed by decapitation 120 min after the injection.

Sensitivity of adrenal cortex to ACTH in vitro

Incubation followed the method of Stachura et al. [25]. Each adrenal gland was chopped into small pieces with a sterile scalpel blade and preincubated in 1 ml DMEM at 37°C under 95% O2–5% CO2 atmosphere for 60 min. Thereafter the buffer was replaced with fresh DMEM, and the adrenals were preincubated for additional 60 min. Following the preincubation, 15-min samples were collected three times adding 10−10 M ACTH into the second fraction. At the conclusion of the experiment, media were removed, centrifuged at 3000 g for 5 min and the supernatant was stored at −20°C until corticosterone and aldosterone measurements. The total secreted amount during the whole observation period (3×15 min) was expressed as area under the curve (AUC).

Hormone assays

Trunk blood was collected by decapitation into ice-cold plastic tubes, centrifugated at 2000 g for 20 min at 4°C and the serum was stored at −20°C until analysed. Because of the small amount of blood in postnatal rats, separate pups were used for ACTH/corticosterone and for plasma renin activity/aldosterone measurements. Samples from a particular experiment were always assessed in the same RIA.

Plasma ACTH concentrations were measured by radioimmunoassay (RIA) in 50 μl of unextracted plasma as described earlier [26]. The intraassay coefficient of variation was 4.7%. Concentrations of plasma corticosterone were measured in 10 μl of unextracted plasma by RIA as described earlier [27]. The intraassay coefficient of variation was 12.3%. Plasma aldosterone levels and plasma renin activity were measured using RIA Aldosterone kit and Angiotensin I RIA kit (Immunotech, France) [28]. The intrassay coefficient of variation was 9.5%. The same RIAs were used to measure corticosterone and aldosterone concentrations in the incubation medias.

Measurements of gene expression of selected receptors and enzymes

Tissue samples of macrodissected brain regions, kidney and liver were collected under RNase free conditions from unstressed adult and postnatal rats and were kept at −70°C. Total RNA was isolated from homogenates of the hypothalamus, pituitary, hippocampus, prefrontal cortex, kidney and liver using RNeasy Mini Kit (Qiagen, Valencia, CA, USA) and then converted to cDNA by High-Capacity cDNA Reverse Transcription Kit (Life Technologies, Foster City, CA, USA). The cDNA samples were pooled for each group and measured in duplicates. Real-time PCR was performed using Power SYBR Green PCR Master Mix (Life Technologies) on ABI StepOnePlus instrument according to the manufacturer's instructions. Primers used for the comparative C T experiments were designed by the Primer Express 3.0 program. Melting curve analysis to confirm the identity of PCR products has been performed by using ABI StepOnePlus instrument's Software v.2.1 according to the instructions of the manufacturer. Gene expression was analyzed by ABI StepOne Software 2.1 program. The primers were the following:

GR forward: 5′-CAT CTT CAG AAC AGC AAA ATC GA-3′, reverse: 5′-AGG TGC TTT GGT CTG TGG GAT A-3′; MR forward: 5′-CCA AGG TAC TTC CAG GAT TTA AAA AC-3′, reverse: 5′-AAC GAT GAT AGA CAC ATC CAA GAA TAC T-3′; 11β-HSD1 forward: 5′-CCT CCA TGG CTG GGA AAA T-3′, reverse: 5′-AAA GAA CCC ATC CAG AGC AAA C-3′; 11β-HSD2 forward: 5′-CGC CGC TTC CTA CAG AAC TT-3′, reverse: 5′-TCC TGG GTT GTG TCA TGA ACA-3′; GAPDH forward: 5′-ACA GCC GCA TCT TCT TGT GC-3′, reverse: 5′-GCC TCA CCC CAT TTG ATG TT-3′.

GAPDH was used as endogenous control. Relative quantity of mRNAs was referred to corresponding samples of the adult Wistar rats based upon the 2−ΔΔCT method.

Immunohistochemistry

Animals were anesthetized at rest by pentobarbital (50 mg/kg intraperitoneal) and perfused transcardially with saline solution (0.9% NaCl) for 2 min, then with 30 mL (pups) or 300 mL (adult) ice cold fixative (4% paraformaldehyde in 0.1 M Borate buffer pH 8). The brains were removed, post-fixed in the fixative for 3 h then placed in PBS 10% sucrose overnight at 4°C. On the next day 30 μm sections were cut in the coronal plane on a freezing microtome and were stored at −20°C in cryoprotectant. The sections were washed first in PBS for 3×10 min and for blocking the endogen peroxidase in H2O2 solution and again 3×5 min in PBS. Then sections were incubated in 2% Normal Goat Serum (Vector, Burlingame, USA) for 60 min. The GR and MR proteins were immuno labeled with rabbit polyclonal antibodies raised against GR and MR (Santa Cruz Biotechnology, USA) for 48 h at 4°C. This was followed by incubation in biotinylated anti-rabbit serum (1∶500; Vector, Burlingame, USA). The antigens were then visualized by conventional Avidin-Biotin-HRP technology (ABC, Vestastain; 1∶1000 TRIS) and developed using 0.05% diaminobenzidine (DAB, Sigma) and 0.01% H2O2 in PBS. Sections were then mounted onto geletine coated slides, dehydrated and coverslipped. Images were taken with a digital camera (NIKON, DMX 1200) coupled to a bright-field microscope (NIKON, Eclipse E400), using a 20× objective, with no further modifications. The following brain areas were investigated: hypothalamus (paraventricular nucleus and medial basal hypothalamus), prefrontal cortex, hippocampus. Representative photomicrographs are shown on figures.

Statistical analysis

Values are presented as mean ± SEM. Data were analysed by analysis of variance using one (age) or two way ANOVA (age, treatment) of the STATISTICA 11.0 software package (StatSoft Inc. Tulsa, Okla, US). Multiple pairwise comparisons where appropriate were made by the Newman–Keuls method. Results of the post hoc analysis are presented on the figures. In case there was no significant interaction, the main effects are indicated in the text only.

Results

Hypoglycaemia

Blood glucose levels decreased significantly at 60 minutes (treatment: F(1,29) = 223.00, p<0.01) (Table 1), and 90 minutes (treatment: F(1,49) = 524.0, p<0.01) (Fig. 1A) following insulin injection. Despite the overall lower blood glucose in pups (age: F(1,50) = 12.1, p<0.01) there was no significant difference in the degree of hypoglycaemia observed in postnatal and in adult rats (no significant interaction between age x treatment). Concentrations of ACTH increased in the stressed groups (at 60 min: treatment F(1,43) = 4.53, p<0.01) (Table 1); (at 90 min: treatment F(1,49) = 58.04, p<0.01) (Fig. 1B) in a similar manner in postnatal and in adult animals at both studied timepoints. Plasma corticosterone levels increased during hypoglycaemic stress, but the elevation was smaller in pups compared to adults at both 60 (age F(1,43) = 311.96, p<0.01; treatment F(1,43) = 305.84, p<0.01; age x treatment F(1,43) = 254.96, p<0.01) (Table 1) and 90 minutes (age F(1,49) = 202.63, p<0.01; treatment F(1,49) = 233.80, p<0.01 age × treatment F(1,49) = 130.70, p<0.01) (Fig. 1C) following insulin injection. Hypoglycaemia had no effect on plasma renin activity, which was lower in pups compared to adults (age F(1,49) = 5.59, p<0.05) (Fig. 1D). On the other hand, hypoglycaemia resulted in a significant rise in aldosterone concentrations in both age groups not only at 60 min (treatment F(1,43) = 18.96, p<0.01) (Table 1), but also 90 min after insulin injection (treatment F(1,49) = 16.95, p<0.01) (Fig. 1B). At 90 min, plasma aldosterone response to insulin injection in 10-day-old rats was significantly higher compared to that in adult animals (age F(1,49) = 10.46, p<0.01; age × treatment F(1,49) = 4.51, p<0.05) (Fig. 1B).

Table 1. Hypoglycaemic stress: sampling 60 min after treatment.

Adult (3 months old) Pup (10-day-old)
Control Hypoglycaemia Control Hypoglycaemia
Blood glucose (mmol/l) 6.2±0.3 3.1±0.2 4.3±0.1 2.1±0.1
ACTH (pg/ml) 92.5±34.8 2942.1±485.1 120.2±21.7 2252.9 ±440.8
Corticosterone (ng/ml) 56.3±7.9 653.2±45.0** 26.0±1.8 53.2±3.9##
Aldosterone (pg/ml) 24.2±4.8 161.7±15.5 46.1±11.1 227.1±63.1
Open in a new tab

Blood samples were collected 60 minutes after insulin injection. The blood glucose level decreased (treatment p<0.01) and the ACTH level increased in the treated groups (treatment p<0.01). The corticosterone level increased after insulin-induced hypoglycaemia, but this elevation was significantly lower compared to adults (age p<0.01; treatment p<0.01 age × treatment p<0.01; treated adults vs. treated juveniles p<0.01). The aldosterone level was elevated after insulin injection in both age groups (treatment p<0.01). *p<0.05, **p<0.01 vs. Control; ##p<0.01 vs. Adult.

Figure 1. Changes in plasma hormone and glucose concentrations during stress of hypoglycaemia in male Wistar rats (n = 12–16) at 90 minutes after the insulin injection.

Figure 1

Open in a new tab

A. Blood glucose (mmol/l) – the effect of treatment and age were statistically significant (p<0.01). B. Plasma ACTH (pg/ml) – the effect of treatment was statistically significant (p<0.01). C. Plasma corticosterone (ng/ml) – the effects of age (p<0.01), treatment (p<0.01) and age x treatment (p<0.01) interaction were statistically significant. D. Plasma renin activity (ng/ml/h) – the effect of age (p<0.05) was statistically significant. E. Plasma aldosterone (pg/ml) – the effects of age (p<0.01), treatment (p<0.01) and age × treatment (p<0.05) interaction were statistically significant. Abbreviations: C: control, unstressed; S: stressed; **p<0.01 vs. appropriate control group; ##p<0.01 vs. appropriate adult group.

Immune challenge

Hormonal changes induced by LPS treatment were very similar to those observed during hypoglycaemia. Plasma ACTH levels increased in response to the immune stressor in both age groups (treatment F(1,33) = 31.90, p<0.01) (Fig. 2A). Concentrations of plasma corticosterone during stress were significantly elevated in both age groups, but the elevation was much lower in the pups (age F(1,33) = 784.84, p<0.01; treatment F(1,33) = 1120.68, p<0.01; age × treatment F(1,33) = 592.04, p<0.01) (Fig. 2B). Plasma renin activity increased in response to immune challenge (treatment F(1,33) = 41.74, p<0.01), exhibiting the highest values in LPS treated pups, which were significantly different from those in LPS injected adults (age F(1,33) = 36.10, p<0.01; age × treatment F(1,33) = 26.12, p<0.01) (Fig. 2C). Changes in plasma aldosterone levels were similar to those in plasma renin activity, however, in contrast to the changes in corticosterone release, the elevation in plasma aldosterone was significantly higher in pups compared to that in adults (age F(1,33) = 30.96, p<0.01; treatment F(1,33) = 60.64, p<0.01; age × treatment F(1,33) = 24.55, p<0.01) (Fig. 2D).

Figure 2. Changes in plasma hormone concentrations during stress of immune challenge at 120 minutes after lipopolysaccharid (LPS) treatment in male Wistar rats (n = 8–10).

Figure 2

Open in a new tab

A. Plasma ACTH (pg/ml) – the effect of treatment was statistically significant (p<0.01). B. Plasma corticosterone (ng/ml) – the effects of age, treatment and age x treatment interaction were statistically significant (p<0.01). C. Plasma renin activity (ng/ml/h) – the effects of age, treatment and age × treatment interaction were significant (p<0.01). D. Plasma aldosterone (pg/ml) – the effects of age, treatment and age × treatment interaction were significant (p<0.01). Abbreviations: C: control, unstressed; S: stressed; **p<0.01 vs. appropriate control group; ##p<0.01 vs. appropriate adult group.

Receptor and enzyme mRNA levels

The resting levels of GR mRNA were lower in 10-day-old rats compared to those in adults in all tissues studied (hypothalamus: F(1,4) = 155.27, p<0.01; hippocampus: F(1,4) = 329.69, p<0.01; prefrontal cortex: F(1,4) = 39.80, p<0.01; liver: F(1,4) = 95.89, p<0.01; kidney: F(1,4) = 76.21, p<0.01) (Fig. 3A). Similarly, MR mRNA levels in pups were lower in comparison with those observed in adults (hypothalamus: F(1,4) = 385.75, p<0.01; hippocampus: F(1,4) = 74.04, p<0.01; prefrontal cortex: F(1,4) = 412.66, p<0.01; liver: F(1,4) = 215.62, p<0.01; kidney: F(1,4) = 227.99, p<0.01) (Fig. 3B).

Figure 3. Glucocorticoid receptor (GR), mineralocorticoid receptor (MR), 11-beta-hydroxysteroid dehydrogenase 1 and 2 (11β-HSD1 and 11β-HSD2) mRNA levels in the hypothalamus, hippocampus, prefrontal cortex, liver and kidney under non-stress conditions (n = 4).

Figure 3

Open in a new tab

A. GR mRNA – the effect of age was statistically significant on all studied area (p<0.01). B. MR mRNA – the effect of age was significant on all studied area (p<0.01). C. 11β-HSD1 mRNA – the effect of age was statistically significant in the hippocampus, prefrontal cortex and kidney (p<0.01). D. 11β-HSD2 mRNA – the effect of age was significant in the hypothalamus, hippocampus and kidney (p<0.01). Abbreviations: Ht: Hypothalamus; Hc: Hippocampus; Pc: Prefrontal cortex; Lr: Liver; Kd: Kidney; ##p<0.01 vs. appropriate adult group.

Tissue specific differences were revealed in the mRNA levels of 11β-HSD1 and 11β-HSD2. In the brain, 11β-HSD1 mRNA levels were lower in the hippocampus and prefrontal cortex of pups compared to the levels found in adult animals (hippocampus: F(1,4) = 168.39, p<0.01; prefrontal cortex: F(1,4) = 56.65, p<0.01), while there was no age effect in the hypothalamus (Fig. 3C). The highest difference was observed in the kidney with very low concentration of 11β-HSD1 mRNA levels in pups (kidney: F(1,4) = 11092.12, p<0.01) (Fig. 3C). In contrast, concentrations of 11β-HSD2 mRNA were higher in 10-day-old pups in the kidney as well as in brain tissues with the exception of the prefrontal cortex (hypothalamus: F(1,4) =  50.98, p<0.01; hippocampus: F(1,4) =  249.61, p<0.01; kidney: F(1,4) =  1815.96, p<0.01) (Fig. 3D). No age effect in the mRNA levels of both 11β-HSD1 and 11β-HSD2 was found in the liver.

Receptor protein levels

GR immunoreactive (ir) neurons were widely distributed in the brains of both adults and pups. Their distribution in the hypothalamus (nucleus paraventricularis hypothalami and mediobasal hypothalamus) and in prefrontal cortex region is presented in Fig. 4. In accordance with the mRNA data, pups showed smaller number of GR positive cell nuclei than adults in all three brain areas studied. In the prefrontal region, not only the number, but also the distribution was substantially different between the two age groups. In the hippocampus, the highest GRir was found in the dentate gyrus region, being lower in pups compared to adults (Fig. 5).

Figure 4. Representative pictures of glucocorticoid receptor immunohistochemistry on adult (approx. 3-month-old) and pup (10-day-old) rat brains.

Figure 4

Open in a new tab

Selected area of the hypothalamus (PVN: nucleus paraventricularis hypothalami, MBH: mediobasal hypothalamus) and prefrontal cortex (PFC) are presented. Arrows represent different distribution of the GR immunoreactivity in adult and pup PFC regions.

Figure 5. Representative pictures of glucocorticoid and mineralocorticoid receptor immunohistochemistry on adult (approx. 3-month-old) and pup (10-day-old) rat hippocampus.

Figure 5

Open in a new tab

Arrows represent different insensity of immunoreactivity at corresponding areas.

The MR proteins were found to be highly expressed in the hippocampal (Fig. 5) and mediobasal hypothalamic (Fig. 6) regions. In the hippocampus, the changes in MRir during the development were site specific. In the CA1 region, the MRir was smaller, while in the region of dentate gyrus it was higher in pups compared to that in adults. In the mediobasal hypothalamic region, the number of MRir positive neurones increased with age (Fig. 6).

Figure 6. Representative pictures of mineralocorticoid receptor immunohistochemistry on adult (approx. 3 month old) and pup (10-day-old) rat brains.

Figure 6

Open in a new tab

Selected area of the hypothalamus (PVN: nucleus paraventricularis hypothalami, MBH: mediobasal hypothalamus) and prefrontal cortex (PFC) are presented. Few immunoeactive cells are present in the PVN and MBH regions.

Sensitivity of adrenal cortex to ACTH in vitro

The overall corticosterone secretion (AUC) was significantly lower in pups compared to adults during the whole observation period (age: F(1,12) =  26,8, p<0.01) (Fig. 7A). Administration ACTH to the incubation medium significantly elevated the secreted amount of corticosterone (treatment: F(1,12) = 5.2, p<0.05). However, the ACTH-induced corticosterone secretion was not different in the two age-groups (no interaction between age × treatment).

Figure 7. In vitro ACTH sensitivity of adult and pup adrenal gland: secretion of corticosterone (A) and aldosterone (B) (n = 4).

Figure 7

Open in a new tab

After 2 h preincubation we collected 3×15 min fractions with 10−10 M ACTH in the second fraction. AUC: area under the curve; the total secreted amount during the whole observation period. **p<0.01 vs. Control; #p<0.05, ##p<0.01 vs. Adults.

Regarding aldosterone secretion, a similar general diminution was visible in pups (age: F(1,9) = 34.8, p<0.01) (Fig. 7B). ACTH administration induced a significant effect (treatment: F(1,9) = 27.4, p<0.01), which was detectable only in adults (age × treatment: F(1,9) = 22.45, p<0.01).

Discussion

Present data provide the first evidence of increased aldosterone responses to stress stimuli during the postnatal period suggesting a shift in the balance between stress-induced glucocorticoid and mineralocorticoid hormone release during the development (Fig. 8). In 10-day-old rat pups, which exhibited the well known reduction in stress-induced corticosterone release during SHRP, stress-induced elevation in aldosterone concentrations were significantly higher compared to those in adulthood. Based on the data obtained it seems unlikely that this phenomenon is stressor-specific or valid for only a single time point. Greater importance of mineralocorticoid compared to glucocorticoid actions in postnatal period are further supported by the present observation of increased renal and brain gene expression of 11β-HSD2, an enzyme enabling preferential effects of aldosterone on MR.

Figure 8. Summary of the gluco- and mineralocorticoid differences during development.

Figure 8

Open in a new tab

Adaptation to stress conditions is fundamental component of survival but the mechanisms seem to be different at different developmental stages (e.g. in adults and in pups). Stressors activate adrenocorticotropin (ACTH) secretion from the pituitary in both adults and pups. However, at the level of the adrenal gland, stimulation of corticosterone secretion is more pronounced in adults compared both to those in pups and to that of aldosterone secretion, while the opposite (namely more pronounced activation of aldosterone secretion) is present in pups. The lower glucocorticoid synthesizing 11β-hydroxysteroid dehydrogenase (11β-HSD1) and gluco- (GR) and mineralocorticoid receptor (MR) mRNA levels in pups seem to be protective mechanisms, preventing the organs (especially the brain) of the pups from excessive glucocorticoid effects. On the other hand, enhanced glucocorticoid degrading 11β-HSD2 expression may enable increased mineralocorticoid effects during the perinatal period.

Dampened stress-induced corticosterone concentrations in 10-day-old pups and facilitated aldosterone release were revealed using two different stress models (hypoglycaemia, LPS), and different timing. The relatively low corticosterone release in response to stress stimuli is well described and it represents the essential characteristics of stress-hyporesponsiveness during the postnatal period [15], [22]–[24]. The present results are strongly supported by the findings obtained by Raff et al. [30] in 7-day-old pups. Mentioned authors found approx. 10 fold elevation of plasma aldosterone to prolonged (7 days) hypoxia without changes in plasma renin activity, while the accompanied rise in corticosterone levels was only approx. 2 fold [30], though this pattern was not fully comfirmed in a later study of the same group [31]. No comparisons beween the responses in pups and adults were made in these studies, however, the work of Raff et al [30] provided a clear demonstration of increased aldosteronogenesis during early postnatal period. In addition, in human infants aged 3–4 months, ACTH-stimulated aldosterone secretion (3 fold) was higher than that of cortisol secretion (1.5 fold) [32]. Interestingly, it is known for a long time that basal, non-stress aldosterone concentrations in plasma are declining during infancy and childhood in humans [29]–[31].

The secretion of ACTH, which is an important secretagogue of aldosterone during stress, was similar in pups and adults in both stress models. During immune challenge, the other physiological regulator, angiotensin II [4], could have been the triggering factor of enhanced aldosterone release in pups as indicated by high increase in plasma renin activity in stressed pups but not adults. The magnitude of LPS stimulated values of plasma renin activity in pups is very high encouraging further research using other stimuli at this age of the development. However, we failed to observe an increase in plasma renin activity during hypoglycaemic stress, which is in accordance with previous findings showing that hypoglycaemia is not associated with an elevation of plasma renin activity or noradrenaline release in both humans and rats [32], [33]. In this experiment, basal values of plasma renin activity were rather high. This appears to be a consequence of necessary fasting included in the procedures. Fasting per se may induce an increase in plasma renin activity [34], which could contribute to the non-responsiveness to subsequent hypoglycaemia. However, during hypoglycaemia, ACTH may play a more important role than angiotensin II in triggering aldosterone release. Nevertheless, we cannot conclude that in pups the regulatory influence of ACTH on aldosterone release is superior to angiotensin II, as ACTH concentrations were not higher and the in vitro sensitivity of adrenals to ACTH was not increased in pups compared to adult animals. Moreover, the in vitro data do not support the hypothesis that ACTH predominantly stimulates aldosterone and not corticosterone secretion during the perinatal period. It cannot be excluded, however, that evaluation of responses to several doses of ACTH would reveal some differences. The involvement of other peptides influencing adrenal aldosterone release, such as leptin [35] or Homer 1 [36], [37] may also be considered, but the exact mechanisms leading to enhanced stress-induced aldosterone release during the perinatal period remain to be elucidated.

Potential functional significance of enhanced aldosterone activity during postnatal period is supported by concomitant higher 11β-HSD2 and/or lower 11β-HSD1 mRNA levels in the kidney and several brain areas of pups compared to adults. The present study clearly shows increased mRNA expression of 11β-HSD2 and decreased expression of 11β-HSD1, GR and MR in the brain and kidney of 10-day-old pups compared to that in adult rats. In consistence with these findings, immunohistochemical analysis revealed similar differences in GR and MR protein levels. Developmental changes in gene expression and activity of 11β-HSD2 in some brain areas and peripheral tissues were reported during both fetal and postnatal periods [38]–[40]. In accordance with the present data, GR mRNA in human [41], mouse [42] and rat [43], [44] brain as well as GRir in zebra finch brain [45] were repeatedly reported to increase during postnatal development. In the hippocampus the MR mRNA levels in mouse [42] as well as MRir levels in rat (Fig. 5) seem to show site-specific developmental changes. Positive developmental impact of low glucocorticoid levels as well as their receptors in early development has been recognized for a long time [18], [19], [46]. Similarly, 11β-HSD2 is thought to protect immature mitotically-active brain cells from exposure to potentially deleterious high levels of glucocorticoids [47], [48]. Apparently, higher basal and stress-induced mineralocorticoid secretion observed in the present study is needed to meet the specific demands of the developing organism. Though aldosterone may influence brain functions in adult animals [12], its action during early development remains to be elucidated.

It is suggested that the main physiological role of enhanced aldosterone secretion in pups is related to the maintenance of water-electrolyte balance [49]. The control of blood volume is considerably more tenuous in the newborn than in adults [50]. Despite low MR mRNA concentrations in pups, locally increased expression of 11β-HSD2 may provide sufficient aldosterone action. Moreover, aldosterone may provide protection from cell volume swelling via non-genomic mechanisms as observed in the pup kidney as well as during lung oedema [51]–[53]. Another possibility is that in pups aldosterone may, at least to some extent, act via GR as suggested [54]. Nevertheless, our attempts to find glucocorticoid-like negative feedback effect of aldosterone in pups have failed (data not shown).

Furthermore, MRs are present also in the heart, blood vessels, adipose tissue and macrophages [55]. Studies using the aldosterone antagonist spironolactone have revealed that aldosterone might modulate cell proliferation and apoptosis in the neonatal rat heart, so influence cardiac growth and development [56]. It may be suggested that throughout the perinatal period aldosterone overtakes the regulatory role of glucocorticoids in certain cellular processes and molecular mechanisms, particularly those related to stress.

Taken together, a primarily mineralocorticoid regulation under stress conditions at the time of postnatal SHRP may be evolutionarily warranted. Though additional information is needed, the results of the present study clearly show a higher stress-induced release of aldosterone in pups compared to adults and strongly suggest greater importance of mineralocorticoid compared to glucocorticoid actions during the postnatal period.

Acknowledgments

Help of Dr. A. Penesova, the supervisor of AG, is appreciated.

Funding Statement

This study was supported by OTKA NN71629 (to DZ), OTKA NN76697 (to KJK) and by the APVV-0028-10, VEGA 2/0118/11 and project of Centre of Excellence CEMAN (to DJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Williams JS, Williams GH (2003) 50th anniversary of aldosterone. J Clin Endocrinol Metab 88: 2364–2372. [DOI] [PubMed] [Google Scholar]
  • 2. Moncek F, Aguilera G, Jezova D (2003) Insufficient activation of adrenocortical but not adrenomedullary hormones during stress in rats subjected to repeated immune challenge. J Neuroimmunol 142: 86–92. [DOI] [PubMed] [Google Scholar]
  • 3. Messerli FH, Nowaczynski W, Honda M, Genest J, Kuchel O (1976) Effects of ACTH on steroid metabolism. J Clin Endocrinol Metab 42: 1074–1080. [DOI] [PubMed] [Google Scholar]
  • 4.Hattangady NG, Olala LO, Bollag WB, Rainey WE (2011) Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol. [DOI] [PMC free article] [PubMed]
  • 5. Reul JM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505–2511. [DOI] [PubMed] [Google Scholar]
  • 6. de Kloet ER, Sarabdjitsingh RA (2008) Everything has rhythm: focus on glucocorticoid pulsatility. Endocrinology 149: 3241–3243. [DOI] [PubMed] [Google Scholar]
  • 7. de Kloet ER (2003) Hormones, brain and stress. Endocr Regul 37: 51–68. [PubMed] [Google Scholar]
  • 8. Naray-Fejes-Toth A, Colombowala IK, Fejes-Toth G (1998) The role of 11beta-hydroxysteroid dehydrogenase in steroid hormone specificity. J Steroid Biochem Mol Biol 65: 311–316. [DOI] [PubMed] [Google Scholar]
  • 9.Zimmerman RS, Frohlich ED (1990) Stress and hypertension. J Hypertens Suppl 8: S103–107. [PubMed]
  • 10. Geerling JC, Loewy AD (2006) Aldosterone-sensitive NTS neurons are inhibited by saline ingestion during chronic mineralocorticoid treatment. Brain Res 1115: 54–64. [DOI] [PubMed] [Google Scholar]
  • 11. Hlavacova N, Bakos J, Jezova D (2010) Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release. J Psychopharmacol 24: 779–786. [DOI] [PubMed] [Google Scholar]
  • 12. Hlavacova N, Jezova D (2008) Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav 54: 90–97. [DOI] [PubMed] [Google Scholar]
  • 13.Hlavacova N, Wes PD, Ondrejcakova M, Flynn ME, Poundstone PK, et al. (2011) Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Int J Neuropsychopharmacol: 1–19. [DOI] [PubMed]
  • 14. Leshem M, Maroun M, Del Canho S (1996) Sodium depletion and maternal separation in the suckling rat increase its salt intake when adult. Physiol Behav 59: 199–204. [DOI] [PubMed] [Google Scholar]
  • 15. Sapolsky RM, Meaney MJ (1986) Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res 396: 64–76. [DOI] [PubMed] [Google Scholar]
  • 16. Levine S (2001) Primary social relationships influence the development of the hypothalamic–pituitary–adrenal axis in the rat. Physiol Behav 73: 255–260. [DOI] [PubMed] [Google Scholar]
  • 17. Levine S (2002) Regulation of the hypothalamic-pituitary-adrenal axis in the neonatal rat: the role of maternal behavior. Neurotox Res 4: 557–564. [DOI] [PubMed] [Google Scholar]
  • 18. Seckl JR (1997) Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 62: 89–94. [DOI] [PubMed] [Google Scholar]
  • 19. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, et al. (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62–67. [DOI] [PubMed] [Google Scholar]
  • 20. Viau V, Sharma S, Meaney MJ (1996) Changes in plasma adrenocorticotropin, corticosterone, corticosteroid-binding globulin, and hippocampal glucocorticoid receptor occupancy/translocation in rat pups in response to stress. J Neuroendocrinol 8: 1–8. [DOI] [PubMed] [Google Scholar]
  • 21. Zelena D, Barna I, Pinter O, Klausz B, Varga J, et al. (2011) Congenital absence of vasopressin and age-dependent changes in ACTH and corticosterone stress responses in rats. Stress 14: 420–430. [DOI] [PubMed] [Google Scholar]
  • 22. Walker CD, Scribner KA, Cascio CS, Dallman MF (1991) The pituitary-adrenocortical system of neonatal rats is responsive to stress throughout development in a time-dependent and stressor-specific fashion. Endocrinology 128: 1385–1395. [DOI] [PubMed] [Google Scholar]
  • 23. Gunnar MR, Donzella B (2002) Social regulation of the cortisol levels in early human development. Psychoneuroendocrinology 27: 199–220. [DOI] [PubMed] [Google Scholar]
  • 24. Quillfeldt P, Poisbleau M, Chastel O, Masello JF (2009) Acute stress hyporesponsive period in nestling Thin-billed prions Pachyptila belcheri. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 195: 91–98. [DOI] [PubMed] [Google Scholar]
  • 25. Stachura ME, Tyler JM, Farmer PK (1985) Human pancreatic growth hormone-releasing factor-44 differentially stimulates release of stored and newly synthesized rat growth hormone in vitro. Endocrinology 116: 698–706. [DOI] [PubMed] [Google Scholar]
  • 26. Zelena D, Kiem DT, Barna I, Makara GB (1999) Alpha 2-adrenoreceptor subtypes regulate ACTH and beta-endorphin secretions during stress in the rat. Psychoneuroendocrinology 24: 333–343. [DOI] [PubMed] [Google Scholar]
  • 27. Zelena D, Mergl Z, Foldes A, Kovacs KJ, Toth Z, et al. (2003) Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint. Am J Physiol Endocrinol Metab 285: E1110–1117. [DOI] [PubMed] [Google Scholar]
  • 28. Ansurudeen I, Kopprasch S, Ehrhart-Bornstein M, Bornstein SR, Willenberg HS (2007) Endothelial cell-mediated regulation of aldosterone release from human adrenocortical cells. Mol Cell Endocrinol 265–266: 150–156. [DOI] [PubMed] [Google Scholar]
  • 29. Sippell WG, Dorr HG, Bidlingmaier F, Knorr D (1980) Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone during infancy and childhood. Pediatr Res 14: 39–46. [DOI] [PubMed] [Google Scholar]
  • 30. Fiselier TJ, Lijnen P, Monnens L, van Munster P, Jansen M, et al. (1983) Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood. Eur J Pediatr 141: 3–7. [DOI] [PubMed] [Google Scholar]
  • 31. Dotsch J, Hohenberger I, Peter M, Sippell W, Dorr HG (2000) Evidence for change of 11beta-hydroxysteroid dehydrogenase activity during infancy and childhood. Pediatr Res 48: 697–700. [DOI] [PubMed] [Google Scholar]
  • 32. Jezova D, Kvetnansky R, Kovacs K, Oprsalova Z, Vigas M, et al. (1987) Insulin-induced hypoglycemia activates the release of adrenocorticotropin predominantly via central and propranolol insensitive mechanisms. Endocrinology 120: 409–415. [DOI] [PubMed] [Google Scholar]
  • 33. Radikova Z, Penesova A, Jezova D, Kvetnansky R, Vigas M, et al. (2003) Body position and the neuroendocrine response to insulin-induced hypoglycemia in healthy subjects. Arch Physiol Biochem 111: 399–405. [DOI] [PubMed] [Google Scholar]
  • 34. Darlington DN, Keil LC, Dallman MF (1989) Potentiation of hormonal responses to hemorrhage and fasting, but not hypoglycemia in conscious adrenalectomized rats. Endocrinology 125: 1398–1406. [DOI] [PubMed] [Google Scholar]
  • 35. Malendowicz LK, Macchi C, Nussdorfer GG, Nowak KW (1998) Acute effects of recombinant murine leptin on rat pituitary-adrenocortical function. Endocr Res 24: 235–246. [DOI] [PubMed] [Google Scholar]
  • 36. Grinevich V, Jezova D, Gambaryan S, Illarionova A, Kolleker A, et al. (2011) Hypertrophy and altered activity of the adrenal cortex in Homer 1 knockout mice. Horm Metab Res 43: 551–556. [DOI] [PubMed] [Google Scholar]
  • 37. Grinevich V, Seeburg PH, Schwarz MK, Jezova D (2012) Homer 1 – a new player linking the hypothalamic-pituitary-adrenal axis activity to depression and anxiety. Endocr Regul 46: 153–159. [DOI] [PubMed] [Google Scholar]
  • 38. Brown RW, Diaz R, Robson AC, Kotelevtsev YV, Mullins JJ, et al. (1996) The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137: 794–797. [DOI] [PubMed] [Google Scholar]
  • 39. Robson AC, Leckie CM, Seckl JR, Holmes MC (1998) 11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain Res Mol Brain Res 61: 1–10. [DOI] [PubMed] [Google Scholar]
  • 40. Wan SL, Liao MY, Sun K (2002) Postnatal development of 11beta-hydroxysteroid dehydrogenase type 1 in the rat hippocampus. J Neurosci Res 69: 681–686. [DOI] [PubMed] [Google Scholar]
  • 41. Sinclair D, Webster MJ, Wong J, Weickert CS (2011) Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development. Mol Psychiatry 16: 504–515. [DOI] [PubMed] [Google Scholar]
  • 42. Schmidt MV, Enthoven L, van der Mark M, Levine S, de Kloet ER, et al. (2003) The postnatal development of the hypothalamic-pituitary-adrenal axis in the mouse. Int J Dev Neurosci 21: 125–132. [DOI] [PubMed] [Google Scholar]
  • 43. Yi SJ, Masters JN, Baram TZ (1994) Glucocorticoid receptor mRNA ontogeny in the fetal and postnatal rat forebrain. Mol Cell Neurosci 5: 385–393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. van Eekelen JA, Bohn MC, de Kloet ER (1991) Postnatal ontogeny of mineralocorticoid and glucocorticoid receptor gene expression in regions of the rat tel- and diencephalon. Brain Res Dev Brain Res 61: 33–43. [DOI] [PubMed] [Google Scholar]
  • 45. Shahbazi M, Schmidt M, Carruth LL (2011) Distribution and subcellular localization of glucocorticoid receptor-immunoreactive neurons in the developing and adult male zebra finch brain. Gen Comp Endocrinol 174: 354–361. [DOI] [PubMed] [Google Scholar]
  • 46. Seckl JR (1994) Glucocorticoids and small babies. Q J Med 87: 259–262. [PubMed] [Google Scholar]
  • 47. Wyrwoll CS, Holmes MC, Seckl JR (2011) 11beta-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front Neuroendocrinol 32: 265–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Holmes MC, Sangra M, French KL, Whittle IR, Paterson J, et al. (2006) 11beta-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids. Neuroscience 137: 865–873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Raff H, Jankowski BM, Bruder ED, Engeland WC, Oaks MK (1999) The effect of hypoxia from birth on the regulation of aldosterone in the 7-day-old rat: plasma hormones, steroidogenesis in vitro, and steroidogenic enzyme messenger ribonucleic acid. Endocrinology 140: 3147–3153. [DOI] [PubMed] [Google Scholar]
  • 50. Low JA, Froese AB, Galbraith RS, Smith JT, Sauerbrei EE, et al. (1993) The association between preterm newborn hypotension and hypoxemia and outcome during the first year. Acta Paediatr 82: 433–437. [DOI] [PubMed] [Google Scholar]
  • 51. Logvinenko NS, Solenov EI, Ivanova LN (2006) A rapid nongenomic effect of aldosterone on intracellular sodium concentration in the distal nephron segment of the rat. Dokl Biochem Biophys 406: 7–10. [DOI] [PubMed] [Google Scholar]
  • 52. Logvinenko NS, Solenov EI, Ivanova LN (2008) Effect of aldosterone on the regulation of the volume of principal cells of rat cortical collecting duct epithelium in early postnatal development. Dokl Biol Sci 423: 385–388. [DOI] [PubMed] [Google Scholar]
  • 53. Olivera WG, Ciccolella DE, Barquin N, Ridge KM, Rutschman DH, et al. (2000) Aldosterone regulates Na, K-ATPase and increases lung edema clearance in rats. Am J Respir Crit Care Med 161: 567–573. [DOI] [PubMed] [Google Scholar]
  • 54. Gauer S, Segitz V, Goppelt-Struebe M (2007) Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor. Nephrol Dial Transplant 22: 3154–3159. [DOI] [PubMed] [Google Scholar]
  • 55. Nguyen Dinh Cat A, Jaisser F (2012) Extrarenal effects of aldosterone. Curr Opin Nephrol Hypertens 21: 147–156. [DOI] [PubMed] [Google Scholar]
  • 56. Sohn HJ, Yoo KH, Jang GY, Lee JH, Choi BM, et al. (2010) Aldosterone modulates cell proliferation and apoptosis in the neonatal rat heart. J Korean Med Sci 25: 1296–1304. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES